DECAF score predicts acute COPD exacerbation mortality Preventing COPD exacerbations has become an important goal in clinical management and a primary outcome in many COPD research trials. This is understandable - not only is the worsening of COPD distressing for patients but exacerbations can be severe enough to result in hospitalization and death. [...]
About milanThis author has not yet filled in any details.
So far milan has created 3 blog entries.
COPD Symposium Online! I’ve been slow to catch up to this development even though I’ve been a part of it. Each year, the European Respiratory Society holds its annual scientific meeting to share late-breaking news in the field of respiratory medicine. It’s a sprawling meeting hosting more than 20,000 international attendees who may [...]
Inspiration Research Contributes to Groundbreaking Study KAMADA Pharmaceutical ("Kamada") conducted a Phase II/III clinical trial on the efficacy of proprietary inhaled Alpha-1 Antitrypsin (AAT) therapy for the treatment of Alpha-1 Antitrypsin Deficiency (AATD or inherited emphysema) which involved a multi-centre, randomized, double-blind, placebo-controlled study designed to evaluate Kamada's formulation of human AAT to [...]